BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 30, 2026
Breaking News: Trump administration impacts continue to roil the life sciences sector
Breaking News: Trump administration impacts continue to roil the life sciences sector
Breaking News: Trump administration impacts continue to roil the life sciences sector
Home
»
Topics
» BioWorld Science, Cancer
BioWorld Science, Cancer
RSS
XL-119 receives orphan drug status for bile duct tumors
March 17, 2004
FDA Advisory Committee sets date to review RSR-13 NDA
March 17, 2004
New alphav integrin inhibitors and their use reported by Sigma-Tau
March 17, 2004
Biomar presents a novel cytotoxic agent isolated from fungal cultures
March 17, 2004
Geron and Merix enter coexclusive license agreement for cancer vaccines
March 17, 2004
Phase I trial of PPI-2458 placed on hold over animal safety data
March 16, 2004
New agents for breast cancer therapy designed by Ohio State U. scientists
March 16, 2004
New VEGFR2/VEGFR3 inhibitors identified at Schering AG
March 16, 2004
New heparanase inhibitors and their use in angiogenesis-related conditions
March 16, 2004
New porphyrin-doxorubicin conjugates prepared and tested at SLIL
March 16, 2004
Previous
1
2
…
2910
2911
2912
2913
2914
2915
2916
2917
2918
…
3672
3673
Next
RSS